PubMed · 13930760
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
L M LINDE, R IVERSON, A MARGOLIN. [Bacterial endocarditis: current bacteriological aspects].. https://pubmed.ncbi.nlm.nih.gov/13930760/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The term organic Mitral Regurgitation (MR) relates to MR secondary to anatomic alteration of the valvular or subvalvular mitral apparatus and refers to rheumatic MR and degenerative MR, i.e. mitral valve prolapse, which has become in the past 20 years the 1st cause of severe MR leading to surgery in western countries. Recent publications on the prognosis of patients with MR secondary to flail leaflet, showed that these patients incur excess mortality rates as compared to expected and that ten years after diagnosis, 90% of those will either be dead or operated on for severe symptoms. On the other hand, analysis of postoperative prognosis showed that the best results of surgical correction were observed in asymptomatic patients with normal pre-operative left ventricular function. The prognosis of these patients was then similar to that expected if a valvular repair was performed, making of mitral repair the hinge point of early surgical strategies.
Explore the source record for details and available documents.
Intravenous drug use is associated with infectious diseases such as endocarditis. Patients often require intensive medical and nursing management in the intensive care unit as well as simultaneous intensive pain, withdrawal, and psychosocial management for the tolerance and behavior issues commonly associated with this population. To provide comprehensive care, the advanced practice nurse needs to understand the relation between intravenous drug use and the development of infective endocarditis. Furthermore, the advanced practice nurse must have skill in making distinctions between pain and opiate withdrawal, selecting a strategy for treating these syndromes, and providing the intravenous drug-using patient with support and aftercare resources.